Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16